13-36346475-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000494062.2(SPART):c.-236G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.249 in 152,766 control chromosomes in the GnomAD database, including 5,240 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.25 ( 5215 hom., cov: 32)
Exomes 𝑓: 0.26 ( 25 hom. )
Consequence
SPART
ENST00000494062.2 5_prime_UTR
ENST00000494062.2 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.431
Genes affected
SPART (HGNC:18514): (spartin) This gene encodes a protein containing a MIT (Microtubule Interacting and Trafficking molecule) domain, and is implicated in regulating endosomal trafficking and mitochondria function. The protein localizes to mitochondria and partially co-localizes with microtubules. Stimulation with epidermal growth factor (EGF) results in protein translocation to the plasma membrane, and the protein functions in the degradation and intracellular trafficking of EGF receptor. Multiple alternatively spliced variants, encoding the same protein, have been identified. Mutations associated with this gene cause autosomal recessive spastic paraplegia 20 (Troyer syndrome). [provided by RefSeq, Nov 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 13-36346475-C-T is Benign according to our data. Variant chr13-36346475-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 311776.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.495 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPART | NM_001142294.2 | c.-2-10643G>A | intron_variant | NP_001135766.1 | ||||
SPART | NM_001142295.2 | c.-3+107G>A | intron_variant | NP_001135767.1 | ||||
SPART | XM_005266314.4 | c.-75+107G>A | intron_variant | XP_005266371.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPART | ENST00000494062.2 | c.-236G>A | 5_prime_UTR_variant | 1/10 | 1 | ENSP00000473599.1 | ||||
SPART | ENST00000451493.5 | c.-3+107G>A | intron_variant | 1 | ENSP00000414147.1 | |||||
SPART | ENST00000355182.8 | c.-2-10643G>A | intron_variant | 5 | ENSP00000347314.4 |
Frequencies
GnomAD3 genomes AF: 0.249 AC: 37796AN: 151980Hom.: 5220 Cov.: 32
GnomAD3 genomes
AF:
AC:
37796
AN:
151980
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.260 AC: 176AN: 676Hom.: 25 Cov.: 0 AF XY: 0.283 AC XY: 146AN XY: 516
GnomAD4 exome
AF:
AC:
176
AN:
676
Hom.:
Cov.:
0
AF XY:
AC XY:
146
AN XY:
516
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.249 AC: 37809AN: 152090Hom.: 5215 Cov.: 32 AF XY: 0.250 AC XY: 18617AN XY: 74336
GnomAD4 genome
AF:
AC:
37809
AN:
152090
Hom.:
Cov.:
32
AF XY:
AC XY:
18617
AN XY:
74336
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1395
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 28, 2022 | - - |
Troyer syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at